Trials / Unknown
UnknownNCT05844696
Electrical Neuromodulation for Focal Epilepsy
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 65 (estimated)
- Sponsor
- National Taiwan University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research is to use electrical neuromodulation on patients with focal epilepsy. The main objective is to assess safety and observe potential therapeutic effects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Soterix MXN-5 HD-tES Model 5005A. Medtronic Percept DBS platform. | 〔Part 1〕Using Soterix MXN-5 HD-tES Model 5005A. Three treatment groups: sham control, continuous tDCS, slow-oscillatory tDCS. 〔Part 2〕Using Medtronic Percept DBS platform. Single group:Neuromodulation. |
Timeline
- Start date
- 2023-05-01
- Primary completion
- 2025-05-01
- Completion
- 2025-08-01
- First posted
- 2023-05-06
- Last updated
- 2023-05-09
Source: ClinicalTrials.gov record NCT05844696. Inclusion in this directory is not an endorsement.